Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Completed · Phase 3 · Has a placebo group
Conditions studied: Dyskinesia, Cerebral Palsy
In brief
The primary objective of this study is to evaluate the efficacy of valbenazine versus placebo on improving chorea in pediatric and adult participants who have dyskinesia due to cerebral palsy (DCP) with choreiform movements.
Key facts
- Study ID
- NCT05206513
- Run by
- Neurocrine Biosciences
- People needed
- 86
- Starts
- 2022-04-15
- Expected to finish
- 2026-03-31
- Last updated by the study team
- 2026-04-29
Who can join
Age: 6 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Neurocrine Clinical Site — San Diego, California, United States
- Neurocrine Clinical Site — Aurora, Colorado, United States
- Neurocrine Clinical Site — Stamford, Connecticut, United States
- Neurocrine Clinical Site — Gulf Breeze, Florida, United States
- Neurocrine Clinical Site — Miami, Florida, United States
- Neurocrine Clinical Site — Orlando, Florida, United States
- Neurocrine Clinical Site — Chicago, Illinois, United States
- Neurocrine Clinical Site — Baltimore, Maryland, United States
- Neurocrine Clinical Site — Boston, Massachusetts, United States
- Neurocrine Clinical Site — Farmington Hills, Michigan, United States
- Neurocrine Clinical Site — Saint Paul, Minnesota, United States
- Neurocrine Clinical Site — New York, New York, United States
- Neurocrine Clinical Site — Cincinnati, Ohio, United States
- Neurocrine Clinical Site — Columbus, Ohio, United States
- Neurocrine Clinical Site — Oklahoma City, Oklahoma, United States
- Neurocrine Clinical Site — Portland, Oregon, United States
- Neurocrine Clinical Site — Dallas, Texas, United States
- Neurocrine Clinical Site — Fort Worth, Texas, United States
- Neurocrine Clinical Site — Houston, Texas, United States
- Neurocrine Clinical Site — Buenos Aires, Argentina
- Neurocrine Clinical Site — Buenos Aires, Argentina
- Neurocrine Clinical Site — Brussels, Belgium
- Neurocrine Clinical Site — Brasília, Brazil
- Neurocrine Clinical Site — Curitiba, Brazil
- Neurocrine Clinical Site — Porto Alegre, Brazil
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.